Literature DB >> 8692921

ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.

S Paul1, L M Breuninger, K D Tew, H Shen, G D Kruh.   

Abstract

MRP is a recently isolated ATP-binding cassette family transporter. We previously reported transfection studies that established that MRP confers multidrug resistance [Kruh, G. D., Chan, A., Myers, K., Gaughan, K., Miki, T. & Aaronson, S. A. (1994) Cancer Res. 54, 1649-1652] and that expression of MRP is associated with enhanced cellular efflux of lipophilic cytotoxic agents [Breuninger, L. M., Paul, S., Gaughan, K., Miki, T., Chan, A., Aaronson, S. A. & Kruh, G. D. (1995) Cancer Res. 55, 5342-5347]. To examine the biochemical mechanism by which MRP confers multidrug resistance, drug uptake experiments were performed using inside-out membrane vesicles prepared from NIH 3T3 cells transfected with an MRP expression vector. ATP-dependent transport was observed for several lipophilic cytotoxic agents including daunorubicin, etoposide, and vincristine, as well as for the glutathione conjugate leukotriene C4 (LTC4). However, only marginally increased uptake was observed for vinblastine and Taxol. Drug uptake was osmotically sensitive and saturable with regard to substrate concentration, with Km values of 6.3 microM, 4.4 microM, 4.2 microM, 35 nM, and 38 microM, for daunorubicin, etoposide, vincristine, LTC4, and ATP, respectively. The broad substrate specificity of MRP was confirmed by the observation that daunorubicin transport was competitively inhibited by reduced and oxidized glutathione, the glutathione conjugates S-(p-azidophenacyl)-glutathione (APA-SG) and S-(2,4-dinitrophenyl)glutathione (DNP-SG), arsenate, and the LTD4 antagonist MK571. This study establishes that MRP pumps unaltered lipophilic cytotoxic drugs, and suggests that this activity is an important mechanism by which the transporter confers multidrug resistance. The present study also indicates that the substrate specificity of MRP is overlapping but distinct from that of P-glycoprotein, and includes both the neutral or mildly cationic natural product cytotoxic drugs and the anionic products of glutathione conjugation. The widespread expression of MRP in tissues, combined with its ability to transport both lipophilic xenobiotics and the products of phase II detoxification, indicates that the transporter represents a widespread and remarkably versatile cellular defense mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692921      PMCID: PMC38911          DOI: 10.1073/pnas.93.14.6929

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles.

Authors:  Y Kamimoto; Z Gatmaitan; J Hsu; I M Arias
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

2.  Expression pattern of MRP in human tissues and adult solid tumor cell lines.

Authors:  G D Kruh; K T Gaughan; A Godwin; A Chan
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

3.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

Authors:  M Müller; C Meijer; G J Zaman; P Borst; R J Scheper; N H Mulder; E G de Vries; P L Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

4.  Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.

Authors:  L M Breuninger; S Paul; K Gaughan; T Miki; A Chan; S A Aaronson; G D Kruh
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

5.  Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure.

Authors:  D Bizub-Bender; J Kulkosky; A M Skalka
Journal:  AIDS Res Hum Retroviruses       Date:  1994-09       Impact factor: 2.205

6.  Cellular and in vitro transport of glutathione conjugates by MRP.

Authors:  H Shen; S Paul; L M Breuninger; P J Ciaccio; N M Laing; M Helt; K D Tew; G D Kruh
Journal:  Biochemistry       Date:  1996-05-07       Impact factor: 3.162

7.  The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance.

Authors:  V Gekeler; W Ise; K H Sanders; W R Ulrich; J Beck
Journal:  Biochem Biophys Res Commun       Date:  1995-03-08       Impact factor: 3.575

8.  How does the MRP/GS-X pump export doxorubicin?

Authors:  T Ishikawa; K Akimaru; M T Kuo; W Priebe; M Suzuki
Journal:  J Natl Cancer Inst       Date:  1995-11-01       Impact factor: 13.506

9.  Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation.

Authors:  E Schneider; H Yamazaki; B K Sinha; K H Cowan
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

10.  Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.

Authors:  C H Versantvoort; H J Broxterman; T Bagrij; R J Scheper; P R Twentyman
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  13 in total

Review 1.  The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Authors:  Margaret M Doherty; William N Charman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells.

Authors:  J Tarasiuk; B Stefańska; I Plodzich; K Tkaczyk-Gobis; O Seksek; S Martelli; A Garnier-Suillerot; E Borowski
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice.

Authors:  R H Stephens; C A O'Neill; J Bennett; M Humphrey; B Henry; M Rowland; G Warhurst
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

4.  Inhibition of the MRP1-mediated transport of the menadione-glutathione conjugate (thiodione) in HeLa cells as studied by SECM.

Authors:  Dipankar Koley; Allen J Bard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-07       Impact factor: 11.205

5.  ATP-dependent transport of reduced glutathione in yeast secretory vesicles.

Authors:  J F Rebbeor; G C Connolly; M E Dumont; N Ballatori
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

6.  Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice.

Authors:  Bao-Jin Zhai; Ze-Yong Shao; Chun-Liang Zhao; Kai Hu; Feng Wu
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

7.  The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin.

Authors:  Igino Rigato; Lorella Pascolo; Cristina Fernetti; J Donald Ostrow; Claudio Tiribelli
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

8.  Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.

Authors:  V D Makhey; A Guo; D A Norris; P Hu; J Yan; P J Sinko
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

9.  The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.

Authors:  K Nooter; G Brutel de la Riviere; M P Look; K E van Wingerden; S C Henzen-Logmans; R J Scheper; M J Flens; J G Klijn; G Stoter; J A Foekens
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 10.  Hepatic glutathione and glutathione S-conjugate transport mechanisms.

Authors:  T K Lee; L Li; N Ballatori
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.